Louis-Martin Boucher

Dr. Louis-Martin Boucher

orcid

Research Focus & Metrics

Academic Career Length

32Years (1995-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2001 in Nature
Verified
Journal Article
Closed access
PDF file
ATAnna Tafuri
Anna Tafuri
ASArda Shahinian
Arda Shahinian
FBFriedhelm Bladt
Friedhelm Bladt
SYSteve K. Yoshinaga
Steve K. Yoshinaga
MJManel Jordana
Manel Jordana
TMTak W. Mak
Tak W. Mak

29 June 2003 in Nature Immunology
Verified
Journal Article
Closed access
PDF file
TMTak W. Mak
Tak W. Mak
ASArda Shahinian
Arda Shahinian
SYSteve K Yoshinaga
Steve K Yoshinaga
AWAndrew Wakeham
Andrew Wakeham
LBLouis-Martin Boucher
Louis-Martin Boucher
ATAnna Tafuri
Anna Tafuri

18 December 2005 in Nature Cell Biology
Verified
Journal Article
Closed access
PDF file
STShine Tu
Shine Tu
Gavin McStayGavin McStay
Gavin McStay
LBLouis-Martin Boucher
Louis-Martin Boucher
TMTak Mak
Tak Mak
HBHelen M. Beere
Helen M. Beere
DGDouglas R. Green
Douglas R. Green

1 June 1995 in Journal of Experimental Medicine
Verified
Journal Article
Open access
PDF file
LBLouis-Martin Boucher
Louis-Martin Boucher
KWK Wiegmann
K Wiegmann
AFA Fütterer
A Fütterer
KPKlaus Pfeffer
Klaus Pfeffer
TMT Machleidt
T Machleidt
MKM Krönke
M Krönke
T cell receptor recognition of antigen can lead either to T lymphocyte differentiation and proliferation or to a state of unresponsiveness, which is dependent on whether appropriate costimulatory signals are provided to the mature T cell. We have investigated a novel intracellular signaling pathway provided by the costimulatory molecule CD28. CD28 engagement triggers the activation of an acidic sphingomyelinase (A-SMase), which results in the generation of ceramide, an important lipid messenger intermediate. A-SMase activation by CD28 occurred in resting as well as in activated primary T cells or leukemic Jurkat cells. In contrast, ligation of either CD3 or CD2 did not result in A-SMase activation. Overexpression of recombinant A-SMase in Jurkat T cells substituted for CD28 with regard to nuclear factor-kB activation. These data suggest that CD28 provides an important costimulatory signal by activation of an acidic sphingomyelinase pathway.

23 September 2005 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
CBChristina Berube
Christina Berube
LBLouis-Martin Boucher
Louis-Martin Boucher
WMWeili Ma
Weili Ma
AWAndrew Wakeham
Andrew Wakeham
LSLeonardo Salmena
Leonardo Salmena
SBSamuel Benchimol
Samuel Benchimol
The p53 tumor suppressor promotes cell cycle arrest or apoptosis in response to diverse stress stimuli. p53-mediated cell death depends in large part on transcriptional up-regulation of target genes. One of these targets, P53-induced protein with a death domain (PIDD), was shown to function as a mediator of p53-dependent apoptosis. Here we show that PIDD is a cytoplasmic protein, and that PIDD-induced apoptosis and growth suppression in embryonic fibroblasts depend on the adaptor protein receptor-interacting protein (RIP)-associated ICH-1/CED-3 homologous protein with a death domain (RAIDD). We provide evidence that PIDD-induced cell death is associated with the early activation of caspase-2 and later activation of caspase-3 and -7. Our results also show that caspase-2 -/- , in contrast to RAIDD -/- , mouse embryonic fibroblasts, are only partially resistant to PIDD. Our findings suggest that caspase-2 contributes to PIDD-mediated cell death, but that it is not the sole effector of this pathway.

1 May 2010 in Journal of Vascular and Interventional Radiology
Verified
Journal Article
Closed access
LLLaurent Letourneau-Guillon
Laurent Letourneau-Guillon
MFMarie E. Faughnan
Marie E. Faughnan
GSGilles Soulez
Gilles Soulez
MGMarie-France Giroux
Marie-France Giroux
VOVincent L. Oliva
Vincent L. Oliva
ETEric Therasse
Eric Therasse